PADCEV (enfortumab vedotin-eifv) approved treatment for locally advanced or mUC patients

A virtual program on an FDA approved treatment option in locally advanced or mUC for patients who have previously received a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced, or metastatic setting.